How, O-J <br/><br/>
Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.  [electronic resource] 

 -  Archives of physiology and biochemistry   
 - 211-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1381-3455 
<br/><br/><label>Standard No.: </label>10.1080/13813450701783281  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--metabolism<br/>Body Weight--drug effects<br/>Cardiovascular Physiological Phenomena--drug effects<br/>Coronary Vessels--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Heart--drug effects<br/>Ion Channels--metabolism<br/>Ischemia--physiopathology<br/>Lipid Metabolism--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mitochondrial Proteins--metabolism<br/>Organ Size--drug effects<br/>Oxidation-Reduction--drug effects<br/>Oxygen Consumption--drug effects<br/>RNA, Messenger--genetics<br/>Reperfusion Injury<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology<br/>Uncoupling Protein 3<br/>Ventricular Function--drug effects